Yoshikazu Uenosono

4.5k total citations · 1 hit paper
142 papers, 3.5k citations indexed

About

Yoshikazu Uenosono is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Yoshikazu Uenosono has authored 142 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Pulmonary and Respiratory Medicine, 63 papers in Surgery and 56 papers in Oncology. Recurrent topics in Yoshikazu Uenosono's work include Gastric Cancer Management and Outcomes (81 papers), Metastasis and carcinoma case studies (43 papers) and Gastrointestinal Tumor Research and Treatment (36 papers). Yoshikazu Uenosono is often cited by papers focused on Gastric Cancer Management and Outcomes (81 papers), Metastasis and carcinoma case studies (43 papers) and Gastrointestinal Tumor Research and Treatment (36 papers). Yoshikazu Uenosono collaborates with scholars based in Japan, Switzerland and United States. Yoshikazu Uenosono's co-authors include Shoji Natsugoe, Takaaki Arigami, Sumiya Ishigami, Shigehiro Yanagita, Takashi Aikou, Hiroshi Okumura, Yasuto Uchikado, Yuko Kijima, Yoshiaki Kita and Hiroshi Kurahara and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer.

In The Last Decade

Yoshikazu Uenosono

135 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial

2018 250 citations Hironori Ishigami, Yoshiyuki Fujiwara et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yoshikazu Uenosono Japan	34	2.0k	1.4k	1.3k	740	526	142	3.5k
Takaaki Arigami Japan	35	1.5k 0.8×	1.9k 1.4×	935 0.7×	425 0.6×	696 1.3×	188	3.5k
Young Soo Park South Korea	30	1.9k 1.0×	1.2k 0.8×	1.1k 0.9×	949 1.3×	245 0.5×	160	3.2k
Nobutsugu Abe Japan	31	1.5k 0.8×	1.5k 1.1×	1.8k 1.4×	791 1.1×	355 0.7×	139	3.1k
Naoto Gotohda Japan	31	1.2k 0.6×	1.8k 1.3×	1.7k 1.3×	243 0.3×	285 0.5×	188	3.5k
Masao Hosokawa Japan	36	1.7k 0.9×	852 0.6×	1.9k 1.5×	207 0.3×	452 0.9×	112	3.8k
Wasat Mansoor United Kingdom	23	1.9k 1.0×	1.9k 1.4×	1.0k 0.8×	655 0.9×	156 0.3×	98	3.1k
Yuji Sakuma Japan	26	1.2k 0.6×	589 0.4×	474 0.4×	521 0.7×	331 0.6×	90	2.3k
Hirokazu Taniguchi Japan	32	2.2k 1.1×	1.0k 0.7×	1.5k 1.1×	1.1k 1.4×	185 0.4×	113	3.3k
Shunichi Okushiba Japan	27	1.2k 0.6×	1.4k 1.0×	1.5k 1.1×	213 0.3×	251 0.5×	150	3.0k
Hiroyuki Matsubayashi Japan	37	1.9k 1.0×	2.4k 1.7×	2.1k 1.6×	762 1.0×	781 1.5×	246	5.1k

Countries citing papers authored by Yoshikazu Uenosono

Since Specialization

Citations

This map shows the geographic impact of Yoshikazu Uenosono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshikazu Uenosono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshikazu Uenosono more than expected).

Fields of papers citing papers by Yoshikazu Uenosono

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshikazu Uenosono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshikazu Uenosono. The network helps show where Yoshikazu Uenosono may publish in the future.

Co-authorship network of co-authors of Yoshikazu Uenosono

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshikazu Uenosono. A scholar is included among the top collaborators of Yoshikazu Uenosono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshikazu Uenosono. Yoshikazu Uenosono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arigami, Takaaki, Yoshikazu Uenosono, Daisuke Matsushita, et al.. (2023). Clinical significance of intraperitoneal paclitaxel combined with systemic chemotherapy for gastric cancer with peritoneal metastasis. International Journal of Clinical Oncology. 28(10). 1371–1377. 5 indexed citations

Suyama, Koichi, Hiroo Katsuya, Naoki Izawa, et al.. (2022). A phase II multicenter trial assessing the efficacy and safety of first-line S-1 + ramucirumab in elderly patients with advanced/recurrent gastric cancer: KSCC1701. European Journal of Cancer. 166. 279–286. 4 indexed citations

Nomura, Takashi, Hiroharu Yamashita, Yoshikazu Uenosono, et al.. (2022). Impact of Tumor Location on the Quality of Life of Patients Undergoing Total or Proximal Gastrectomy. Journal of the Korean Gastric Cancer Association. 22(3). 235–235. 4 indexed citations

Arigami, Takaaki, Daisuke Matsushita, Keishi Okubo, et al.. (2022). A prognostic scoring system for conversion surgery after trastuzumab-based chemotherapy for human epidermal growth factor receptor 2-positive advanced gastric cancer. Surgery Today. 52(12). 1721–1730. 2 indexed citations

Matsushita, Daisuke, Keishi Okubo, Masataka Shimonosono, et al.. (2022). Clinical Significance of Eligibility Criteria Determined by the SPIRITS Trial in Patients with Advanced Gastric Cancer. Oncology. 101(1). 12–21. 2 indexed citations

Okubo, Keishi, Takaaki Arigami, Daisuke Matsushita, et al.. (2021). The Clinical Significance of CA19-9 and Tumor Size Ratios for Predicting Prognosis After Conversion Surgery in Patients With Stage IV Gastric Cancer. Anticancer Research. 41(11). 5643–5649. 2 indexed citations

Matsushita, Daisuke, Yoshikazu Uenosono, Takaaki Arigami, et al.. (2021). Clinical significance of circulating tumor cells in the response to trastuzumab for HER2-negative metastatic gastric cancer. Cancer Chemotherapy and Pharmacology. 87(6). 789–797. 12 indexed citations

Okubo, Keishi, Takaaki Arigami, Daisuke Matsushita, et al.. (2020). Evaluation of postoperative quality of life by PGSAS-45 following local gastrectomy based on the sentinel lymph node concept in early gastric cancer. Gastric Cancer. 23(4). 746–753. 21 indexed citations

Kinami, Shinichi, Masazumi Takahashi, Takashi Urushihara, et al.. (2018). Background factors influencing postgastrectomy syndromes after various types of gastrectomy. World Journal of Clinical Cases. 6(16). 1111–1120. 16 indexed citations

10.

Arigami, Takaaki, Yoshikazu Uenosono, Shigehiro Yanagita, et al.. (2017). Clinical significance of circulating tumor cells in blood from patients with gastric cancer. Annals of Gastroenterological Surgery. 1(1). 60–68. 10 indexed citations

11.

Aizawa, Masaki, Hironori Ishigami, Hiroshi Yabusaki, et al.. (2017). Phase II study of intraperitoneal paclitaxel plus S-1/paclitaxel for gastric cancer with positive peritoneal cytology: CY-PHOENIX trial.. Journal of Clinical Oncology. 35(4_suppl). 96–96. 8 indexed citations

12.

Sasaki, Ken, Yasuto Uchikado, Hiroshi Okumura, et al.. (2017). Role of 18F-FDG-PET/CT in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy. Anticancer Research. 37(2). 859–864. 13 indexed citations

13.

Kurahara, Hiroshi, Kosei Maemura, Yuko Mataki, et al.. (2016). Preoperative biliary drainage-related inflammation is associated with shorter survival in biliary tract cancer patients. International Journal of Clinical Oncology. 21(5). 934–939. 7 indexed citations

14.

Arigami, Takaaki, Yoshikazu Uenosono, Sumiya Ishigami, et al.. (2016). A Novel Scoring System Based on Fibrinogen and the Neutrophil-Lymphocyte Ratio as a Predictor of Chemotherapy Response and Prognosis in Patients with Advanced Gastric Cancer. Oncology. 90(4). 186–192. 29 indexed citations

15.

Arigami, Takaaki, Yoshikazu Uenosono, Sumiya Ishigami, et al.. (2016). Clinical Impact of Stomach-partitioning Gastrojejunostomy with Braun Enteroenterostomy for Patients with Gastric Outlet Obstruction Caused by Unresectable Gastric Cancer. Anticancer Research. 36(10). 5431–5436. 9 indexed citations

16.

Matsushita, Daisuke, Yoshikazu Uenosono, Takaaki Arigami, et al.. (2015). Clinical Significance of Circulating Tumor Cells in Peripheral Blood of Patients with Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. 22(11). 3674–3680. 49 indexed citations

17.

Sakoda, Masahiko, Shinichi Ueno, Satoshi Iino, et al.. (2014). Anatomical Laparoscopic Hepatectomy for Hepatocellular Carcinoma Using Indocyanine Green Fluorescence Imaging. Journal of Laparoendoscopic & Advanced Surgical Techniques. 24(12). 878–882. 36 indexed citations

18.

Natsugoe, Shoji, Masataka Matsumoto, Hiroshi Okumura, et al.. (2011). [Neoadjuvant chemoradiotherapy for advanced esophageal cancer].. PubMed. 112(2). 111–6. 1 indexed citations

19.

Ishigami, Sumiya, Shoji Natsugoe, Hiroshi Okumura, et al.. (2007). Clinical Implication of CXCL12 Expression in Gastric Cancer. Annals of Surgical Oncology. 14(11). 3154–3158. 38 indexed citations

20.

Owaki, Tetsuhiro, Heiji Yoshinaka, Katsuhiko Ehi, et al.. (2004). Endoscopic quadrantectomy for breast cancer with sentinel lymph node navigation via a small axillary incision. The Breast. 14(1). 57–60. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact